£520.00

The 2023-2028 Outlook for Gynecologic Oncology in the United States

Price data last checked 84 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 7 days • 7 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 27 January 2026 29 January 2026 30 January 2026 01 February 2026

Price Distribution

Price distribution over 7 days • 1 price levels

Days at Price
7 days 0 2 4 5 7 £520 Days at Price

Price Analysis

Most common price: £520 (7 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 7 days

Product Specifications
Format
paperback
ASIN
B0BLR6RQHN
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
2023-2028 Outlook for Endometrial Cancer Treatments in US
97% match

2023-2028 Outlook for Endometrial Cancer Treatments in US

£520.00 03 Mar 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
97% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 20 Jan 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
97% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 26 Jan 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in the United States
97% match

The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 14 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
97% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
97% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers
96% match

The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers

£795.00 02 Apr 2026
The 2023-2028 Outlook for Female Contraceptives in the United States
96% match

The 2023-2028 Outlook for Female Contraceptives in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States
96% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Contraceptives in the United States
96% match

The 2023-2028 Outlook for Contraceptives in the United States

£520.00 24 Jan 2026
The 2023-2028 World Outlook for Genomics in Cancer Care
96% match

The 2023-2028 World Outlook for Genomics in Cancer Care

£795.00 25 Jan 2026